Director Omnibus Decision – 26 IPRsOctober 19, 2026
Notice of Decisions on Institution — 2026-10-19
Patent Trial and Appeal Board
Total Proceedings
26
in this notice
Total Denied
2
discretionary + merits
Total Instituted
10
trial granted
Grant Rate
83%
17% denial rate
Trial Instituted· 10 proceedings
PGR2026-00045IPR2026-00316IPR2026-00348IPR2026-00359IPR2026-00317PGR2026-00051IPR2026-00349IPR2026-00360IPR2026-00358IPR2026-00374
Discretionary Denial· 2 proceedings
IPR2026-00375IPR2026-00263
Referred for merits review· 14 proceedings
IPR2026-00341IPR2026-00380IPR2026-00407IPR2026-00376IPR2026-00381PGR2026-00059IPR2026-00377IPR2026-00382PGR2026-00060IPR2026-00378IPR2026-00397PGR2026-00061IPR2026-00379IPR2026-00400
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases. After review of discretionary considerations, 14 proceedings will be reviewed for merits and non-discretionary considerations; their institution decisions will come in a later notice.
New to PTAB and post-grant? Start with IPR vs. PGR: Inter Partes Review and Post-Grant Review Compared
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23
- PTAB Director Review · Sept. 23, 2026Nearmap US, Inc. v. Eagle View Technologies, Inc.
- PTAB Director Review · Aug. 25, 2026Aesthetic Management Partners, LLC and Aesthetic Management Partners, Inc. v. HydraFacial LLC